This may explain why neutrophil-derived ROS selectively impacted on CD27− γδ17 T-cell proliferation (Fig 1A and 1D) compared to CD27+ γδ T cells (S3A Fig), CD8+ or CD4+ T cells (Fig 1B) in neutrophil-rich tumor models. This evidence concerns the gene CD27 and neoplasm.